Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Mind Medicine (MindMed) Inc MNMD

Alternate Symbol(s):  N.MMED.WA | N.MMED.WR | N.MMED.WS | N.MMED

Mind Medicine (MindMed) Inc. is a clinical-stage biopharmaceutical company, which is engaged in developing products to treat brain health disorders. It is developing a pipeline of product candidates, with and without acute perceptual effects, targeting neurotransmitter pathways. This specifically includes pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM-120 and MM-402, the Company's product candidates. MM120, is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that it is developing for the treatment of generalized anxiety disorder (GAD). MM-120 is also being studied in a subperceptual repeat administration dosing regimen for the treatment of attention deficit hyperactivity disorder (ADHD). MM-402, also referred to as R(-)-MDMA, is the Company's form of the R-enantiomer of 3,4-methylenedioxymethampheta (MDMA), which the Company is developing for the treatment of autism spectrum disorder (ASD).


NDAQ:MNMD - Post by User

Bullboard Posts
Comment by josameyeron Jul 27, 2010 8:40am
378 Views
Post# 17299147

RE: RE: Looking Forward to the Underground Product

RE: RE: Looking Forward to the Underground ProductStanley I thank you for your input.From all that I can gather, we now have the right person in charge of operations at the helm.I am hoping for some good news regarding the current drilling.I am not sure if the nugget effect will have a great impact on drilling results.There seems to be a lot of trading on the buy side by anonymous.I am a bit at a loss regarding the sale of our share of Montana tunnels that was sold for about 9 million if memory serves. The Callais properties were put up as collateral, am not sure where those properties are, and how valuable they might be.They might be in Nevada..At any rate, as the gold production ramps up  more gold is found with the current drilling, debt paid off gradually, hedge reduced and no further dilution in stock.With all the property we currently have, in my view we are in a good position to move forward in a big way. My opinion only Have a great day.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse